A.M. Best has assigned a debt rating of “bbb+” to the $250
million, 4.25% senior unsecured notes due 2024, issued by Symetra
Financial Corporation (Symetra) (headquartered in Bellevue, WA)
[NYSE: SYA]. Concurrently, A.M. Best has assigned indicative ratings of
“bbb+” to senior unsecured debt, “bbb” to subordinated debt, “bbb-” to
junior subordinated debt and “bbb-” to preferred shares of the recently
filed shelf registration of Symetra.
Principal Real Estate Income Fund (the “Fund”), which is traded on the
New York Stock Exchange under the symbol “PGZ,” announced the
declaration of monthly distributions of $0.14 per common share, payable
on the dates noted below.
Campus Crest Communities, Inc. (NYSE: CCG), a leading developer,
builder, owner and manager of high-quality student housing properties,
today announced that it has hired Aaron Halfacre, CFA as an Executive
Vice President and Head of Capital Markets, effective August 1, 2014.
Declares Quarterly Dividend Conference Call to Discuss Results Scheduled for 10:00 AM ET Today NEW YORK , July 31, 2014 /PRNewswire/ -- BGC Partners, Inc. (NASDAQ: BGCP) ("BGC Partners," "BGC," or "the Company"), a leading global brokerage company servicing the financial and real estate markets, today reported its financial results for the quarter ended June 30 , 2014.
County Commerce Bank (OTCBB:CNYB), the only bank headquartered in
Ventura and Santa Barbara Counties recognized by The Findley Reports as
a “Super Premier Performing Bank” based on 2013 operating results,
continued its strong earnings performance for the second quarter of 2014.
IRVINE, Calif., July 31, 2014 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX) , a molecular diagnostics company performing DNA-based testing services for developmental disorders and cancer diagnostics, today announced that its SNP-based chromosomal microarray analysis (CMA) test for miscarriage analysis, the CombiSNP™ Array for Pregnancy Loss , or products of conception, has received conditional approval from the New York Department of Health (NYDOH). This approval is for testing on fresh and formalin fixed paraffin embedded (FFPE) patient samples.
URAC's new accreditation validates the quality of CVS/pharmacy's patient care WOONSOCKET, R.I. and WASHINGTON , July 31, 2014 /PRNewswire/ -- CVS/pharmacy and URAC announced today that CVS/pharmacy is the first pharmacy in the nation to earn the new Community Pharmacy accreditation from URAC, the leading health care accreditation organization that establishes quality standards for the health care industry.
BOISE, Idaho , July 31, 2014 /PRNewswire/ -- IDACORP, Inc. (NYSE: IDA) reported second quarter 2014 net income attributable to IDACORP of $44.5 million , or $0.89 per diluted share, compared with $46.5 million , or $0.93 per diluted share, in the second quarter of 2013.
Atlas Air Worldwide Holdings, Inc. (Nasdaq:AAWW), a leading global
provider of outsourced aircraft and aviation operating services, today
announced adjusted net income attributable to common stockholders of
$15.9 million, or $0.63 per diluted share, for the three months ended
June 30, 2014, compared with $20.4 million, or $0.79 per diluted share,
for the three months ended June 30, 2013.
Latista to Exhibit at 2014 ASHE Annual Conference American Society for Healthcare Engineering's trusted event focuses on helping professionals construct and maintain the most advanced healthcare facilities.
Incyte Corporation (Nasdaq: INCY) today reported 2014 second-quarter
financial results, including revenue from Jakafi ®
(ruxolitinib), which is approved by the U.S. Food & Drug Administration
(FDA) for the treatment of patients with intermediate or high-risk
myelofibrosis (MF). The Company highlighted its strong financial
position, driven by growing Jakafi sales in the U.S. and Jakavi ®
(ruxolitinib) royalties outside the U.S., as well as the submission of
the ruxolitinib supplemental New Drug Application (sNDA) in the U.S. for
patients with uncontrolled polycythemia vera (PV). The Company also
discussed its expanding clinical pipeline, which includes pivotal as
well as proof of concept studies, and the multiple data presentations
for the Company’s product candidates that were made at the recent
American Society of Clinical Oncology (ASCO) meeting.
MCLEAN, Va., July 31, 2014 (GLOBE NEWSWIRE) -- Iridium Communications Inc. (Nasdaq:IRDM) ("Iridium") today reported financial results for the second quarter of 2014 and affirmed its full-year 2014 and long-range outlook.
Q2 Highlights: Sales of $68.4 million, up 29% from Q2 2013 driven by strength in Towers and Gearing Gross profit margin (ex. restructuring) of 13.4%, up 470 bp from Q2 2013 Adjusted EBITDA of $5.9 million, up 67% from Q2 2013 EPS of $.12, significantly ahead of Q2 2013 $34 million tower order announced after quarter end
CICERO, Ill., July 31, 2014 (GLOBE NEWSWIRE) -- Broadwind Energy, Inc. (Nasdaq:BWEN) reported sales of $68.4 million for the second quarter of 2014, a 29% increase compared to $52.9 million in the second quarter of 2013.
First quarter sales were up 3% to $142.9 million; Sales per shipping day increased 5% Gross margin expanded 60 basis points Generated $6.5 million of cash from operations in first quarter
AMHERST, N.Y., July 31, 2014 (GLOBE NEWSWIRE) -- Columbus McKinnon Corporation (Nasdaq:CMCO) , a leading designer, manufacturer and marketer of material handling products and services, today announced financial results for its fiscal 2015 first quarter, which ended June 30, 2014.
Pharmaceuticals, Inc. (NASDAQ: PCRX) today provided updates on the
success of EXPAREL®
(bupivacaine liposome injectable suspension) for postsurgical pain in
the United States and announced consolidated financial results for the
second quarter ended June 30, 2014.
TULSA, Okla., July 31, 2014 (GLOBE NEWSWIRE) -- Helmerich & Payne, Inc. (NYSE:HP) reported net income of $192.3 million ($1.75 per diluted share) from operating revenues of $952.1 million for the third quarter of fiscal 2014, compared to net income of $266.2 million ($2.46 per diluted share) from operating revenues of $840.2 million during the third fiscal quarter of 2013, and net income of $174.6 million ($1.59 per diluted share) from operating revenues of $893.4 million during the second fiscal quarter of 2014.
Swift Energy Company (NYSE:SFY) announced second quarter 2014 results
today including a 24% increase in production, a 24% increase in adjusted
cash flow and a 20% increase in net income, when compared to the second
quarter of 2013.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.